Science Explorer Back to mapMap
Discussion
Researcher · Hokkaido Pharmaceutical University · Japan

Takashi Amiya

Takashi Amiya publishes mostly in Pharmacology, Organic Chemistry and Molecular Biology, on topics such as Plant-based Medicinal Research, Seaweed-derived Bioactive Compounds and Chemical synthesis and alkaloids.

OpenAlex
World rank
#6,292,361
of 7,710,434 ranked researchers
Rank in Japan
#245,537
of 383,136
Works
55
Citations
805
Citations per work
14.6
h-index
17
i10-index 24Top 26% in Pharmacology (Pharmacology, Toxicology and Pharmaceutics)
Takashi Amiya

What does Takashi Amiya research?

Takashi Amiya's work is mostly in Pharmacology, Toxicology and Pharmaceutics (29%), Chemistry (28%), Biochemistry, Genetics and Molecular Biology (9%).

Life Sciences: 25 works · 44.7% of their workPharmacology, Toxicology and Pharmaceutics: 16 works · 29.5% of their workPharmacology: 16 works · 29.5% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 8.9% of their workMolecular Biology: 5 works · 8.9% of their workAgricultural and Biological Sciences: 3 works · 6.3% of their workAquatic Science: 3 works · 6.3% of their workPhysical Sciences: 15 works · 27.7% of their workChemistry: 15 works · 27.7% of their workOrganic Chemistry: 13 works · 23.2% of their workSpectroscopy: 2 works · 4.5% of their workEverything else: 13 works · 24.0% of their workHealth Sciences: 2 works · 3.6% of their workMedicine: 2 works · 3.6% of their workOncology: 2 works · 3.6% of their workTHEIR WORKTakashi Amiya55works
Life Sciences45%Physical Sciences28%Health Sciences4%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Pharmacology, Toxicology and Pharmaceutics1629.5%
    2. Biochemistry, Genetics and Molecular Biology58.9%
    3. Agricultural and Biological Sciences36.3%
    1. Chemistry1527.7%
  3. Everything else1324.0%
    1. Medicine23.6%
  1. 1Pharmacology30% of their works
  2. 2Organic Chemistry23% of their works
  3. 3Molecular Biology9% of their works
  4. 4Aquatic Science6% of their works
  5. 5Spectroscopy4% of their works
  6. 6Oncology4% of their works

Research topics

Which keywords describe Takashi Amiya's research?

The keywords of their largest research topics: Aconitum Alkaloids, Traditional Chinese Medicine, Alkaloids, Amaryllidaceae, Amides, Bioactive Compounds, Chemoselective Synthesis and Galanthamine.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Aconitum Alkaloids311 topic
  2. Traditional Chinese Medicine311 topic
  3. Alkaloids142 topics
  4. Amaryllidaceae71 topic
  5. Amides71 topic
  6. Bioactive Compounds71 topic
  7. Chemoselective Synthesis71 topic
  8. Galanthamine71 topic
  9. Seaweed71 topic
  10. Chemotherapy-Induced Peripheral Neuropathy31 topic
  11. Chiral Separation31 topic
  12. DNA31 topic
  13. Liquid Chromatography31 topic
  14. Taxanes31 topic
  15. Topoisomerases31 topic
  16. Saponins21 topic
  17. Triterpenoids21 topic

Where does Takashi Amiya work?

Takashi Amiya's main affiliation in the publication record is Hokkaido Pharmaceutical University, Japan.

How many publications and citations does Takashi Amiya have?

OpenAlex counts 55 works and 805 citations for Takashi Amiya, an h-index of 17, ranking #6,292,361 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Takashi Amiya. Posts are plain text and can be reported.